WANG Yidan, GUO Qifa, SHEN Tongtao. Clinical effect of erector spinal plane block combined with opiate-free general anesthesia in breast cancer surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(6): 101-105, 122. DOI: 10.7619/jcmp.20223281
Citation: WANG Yidan, GUO Qifa, SHEN Tongtao. Clinical effect of erector spinal plane block combined with opiate-free general anesthesia in breast cancer surgery[J]. Journal of Clinical Medicine in Practice, 2023, 27(6): 101-105, 122. DOI: 10.7619/jcmp.20223281

Clinical effect of erector spinal plane block combined with opiate-free general anesthesia in breast cancer surgery

More Information
  • Received Date: November 02, 2022
  • Revised Date: December 28, 2022
  • Available Online: April 11, 2023
  • Objective 

    To observe clinical effect of erector spinae plane block (ESPB) combined with opioid-free general anesthesia in patients undergoing breast cancer surgery.

    Methods 

    A total of 60 female patients aged 20 to 65 years and American Society of Association (ASA) type of class Ⅰ to Ⅱ undergoing unilateral breast cancer surgery were selected as study objects, and were randomly divided into group E(ESPB combined with opioid-free general anesthesia) and group C (opioid-free general anesthesia), with 30 cases in each group. The mean arterial pressure (MAP) and heart rate (HR) were recorded before anesthesia induction (T0), after anesthesia induction (T1), after laryngeal mask implantation (T2), after skin incision (T3), 1 h after operation (T4) and at the end of surgery (T5). Visual analogue scale (VAS) scores at rest and activity and analgesia within 48 h after surgery were recorded at PACU, postoperative 2 h, 6 h, 12 h, 24 h and 48 h. Postoperative extubation time, PACU residence time, first anal exhaust and ambulation time, and the occurrence of adverse reactions within 48 h after surgery were observed and recorded in two groups.

    Results 

    Compared with T0, MAP and HR were all lower at T1 to T4 in group C (P < 0.05). Compared withT0, MAP at T1 to T4 and HR at T1 to T5 in group E were decreased, and the differences were statistically significant (P < 0.05). Compared with group C, group E had a higher MAP at T1 and a lower HR at T4, and the difference was statistically significant (P < 0.05). There were 12 (41.4%) and 4 (14.3%) cases of intraoperative hypotension in group C and group E, respectively. The proportion of hypotension in the group E was lower than that in group C (P < 0.05). Compared group C, the VAS scores entering PACU and within postoperative 2 h were lower, and VAS score at activity entering PACU was lower(P < 0.05). PACU residence time and first anal exhaust time in the group E were shorter than those in group C (P < 0.05). No obvious bradycardia was observed in the two groups within 48 h after operation. The incidence of total adverse reactions in the group E within 48 h after surgery was lower than that in group C, especially the incidence of postoperative nausea and vomiting, the difference was statistically significant (P < 0.05).

    Conclusion 

    ESPB combined with opioid-free general anesthesia has satisfactory clinical efficacy and less complication, which is beneficial for Rapid postoperative recovery.

  • [1]
    SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
    [2]
    刘元雪, 李峰, 王艺丹, 等. 无阿片药麻醉临床应用进展[J]. 国际麻醉学与复苏杂志, 2021, 42(5): 505-509. doi: 10.3760/cma.j.cn321761-20200601-00284
    [3]
    郭其发, 杨成亮, 王艺丹, 等. 无阿片药麻醉诱导对气管插管患者血流动力学的影响[J]. 实用临床医药杂志, 2022, 26(22): 56-59. doi: 10.7619/jcmp.20221415
    [4]
    WESMILLER S W, BENDER C M, CONLEY Y P, et al. A prospective study of nausea and vomiting after breast cancer surgery[J]. J Perianesth Nurs, 2017, 32(3): 169-176. doi: 10.1016/j.jopan.2015.12.009
    [5]
    XIN L, HOU N, ZHANG Z, et al. The effect of preoperative ultrasound-guided erector spinae plane block on chronic postsurgical pain after breast cancer surgery: a propensity score-matched cohort study[J]. Pain Ther, 2022, 11(1): 93-106. doi: 10.1007/s40122-021-00339-9
    [6]
    SINGH N P, MAKKAR J K, KUBERAN A, et al. Efficacy of regional anesthesia techniques for postoperative analgesia in patients undergoing major oncologic breast surgeries: a systematic review and network meta-analysis of randomized controlled trials[J]. Can J Anaesth, 2022, 69(4): 527-549. doi: 10.1007/s12630-021-02183-z
    [7]
    SAADAWI M, LAYERA S, ALISTE J, et al. Erector spinae plane block: a narrative review with systematic analysis of the evidence pertaining to clinical indications and alternative truncal blocks[J]. J Clin Anesth, 2021, 68: 110063. doi: 10.1016/j.jclinane.2020.110063
    [8]
    BHARDWAJ S, GARG K, DEVGAN S. Comparison of opioid-based and opioid-free TIVA for laparoscopic urological procedures in obese patients[J]. J Anaesthesiol Clin Pharmacol, 2019, 35(4): 481-486. doi: 10.4103/joacp.JOACP_382_18
    [9]
    WANG K, WU M, XU J, et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis[J]. Br J Anaesth, 2019, 123(6): 777-794. doi: 10.1016/j.bja.2019.07.027
    [10]
    HUBLET S, GALLAND M, NAVEZ J, et al. Opioid-free versus opioid-based anesthesia in pancreatic surgery[J]. BMC Anesthesiol, 2022, 22(1): 9. doi: 10.1186/s12871-021-01551-y
    [11]
    KRANKE P, JOKINEN J, PACE N L, et al. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery[J]. Cochrane Database Syst Rev, 2015(7): CD009642.
    [12]
    DE CASSAI A, BOSCOLO A, GERALDINI F, et al. Effect of dexmedetomidine on hemodynamic responses to tracheal intubation: a meta-analysis with meta-regression and trial sequential analysis[J]. J Clin Anesth, 2021, 72: 110287. doi: 10.1016/j.jclinane.2021.110287
    [13]
    CLIVIO S, PUTZU A, TRAMōR M R. Intravenous lidocaine for the prevention of cough: systematic review and meta-analysis of randomized controlled trials[J]. Anesth Analg, 2019, 129(5): 1249-1255. doi: 10.1213/ANE.0000000000003699
    [14]
    LIU C, WANG W, SHAN Z, et al. Dexmedetomidine as an adjuvant for patients undergoing breast cancer surgery: a meta-analysis[J]. Medicine: Baltimore, 2020, 99(50): e23667. doi: 10.1097/MD.0000000000023667
    [15]
    BELOEIL H, GAROT M, LEBUFFE G, et al. Balanced opioid-free anesthesia with dexmedetomidine versus balanced anesthesia with remifentanil for major or intermediate noncardiac surgery[J]. Anesthesiology, 2021, 134(4): 541-551. doi: 10.1097/ALN.0000000000003725
    [16]
    XUAN C, YAN W, WANG D, et al. The facilitatory effects of adjuvant pharmaceutics to prolong the duration of local anesthetic for peripheral nerve block: a systematic review and network meta-analysis[J]. Anesth Analg, 2021, 133(3): 620-629. doi: 10.1213/ANE.0000000000005640
  • Related Articles

    [1]REN Meng, HE Yana. Visualization analysis of chemotherapy-induced nausea and vomiting from 2013 to 2023[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 118-122. DOI: 10.7619/jcmp.20232710
    [2]WANG Pengcheng, WANG Di, JI Xueli, YAN Keli, ZHANG Li, HUANG Xihua, TAO Hua, ZHU Ping. An overview of systematic reviews on efficacy of non-pharmacological intervention for chemotherapy induced nausea and vomiting[J]. Journal of Clinical Medicine in Practice, 2023, 27(9): 53-58, 64. DOI: 10.7619/jcmp.20223558
    [3]QIN Baodong, JIAO Xiaodong, ZANG Yuansheng. Comprehensive prevention and treatment of nautical motion sickness from perspective of precise prevention for chemotherapy induced nausea and vomiting[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 125-128. DOI: 10.7619/jcmp.20220986
    [4]ZHANG Guoping, YANG Chuansheng, CHEN Zhuorong, WU Ying, KANG Ning. Analysis in efficacy and safety of aprepitant in preventing nausea and vomiting due to chemotherapy for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(13): 81-84. DOI: 10.7619/jcmp.20210745
    [5]HUANG Tao, GAN Xuemei, CHEN Ming. Effect of aripitan combined with dexamethasone sodium phosphate and panolosetron in prevention of nausea and vomiting after chemotherapy for osteosarcoma[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 72-75. DOI: 10.7619/jcmp.202005018
    [6]CHENG Menghui, LU Yongmei, XIAO Wenli, LI Yuchan, WU Jiahua, NIU Caili. Clinical efficacy of lemon ginger aroma inhalation for chemotherapy-related nausea and vomiting in breast cancer patients[J]. Journal of Clinical Medicine in Practice, 2018, (14): 97-100. DOI: 10.7619/jcmp.201814028
    [7]JIANG Hong, WANG Xin, PENG Yan. Effect of evidence-based nursing on postoperative nausea and vomiting in patients with thyroid surgery and nursing countermeasures[J]. Journal of Clinical Medicine in Practice, 2017, (6): 111-113,117. DOI: 10.7619/jcmp.201706034
    [8]WANG Yaorong, LU Xiaoling. Clinical efficacy Xiaochaihu Decoction together with Haoqin gallbladder-clearing Decoction in the treatment of chemotherapy-induced nausea and vomiting[J]. Journal of Clinical Medicine in Practice, 2017, (2): 47-49. DOI: 10.7619/jcmp.201702015
    [9]CAI Zhihui, ZHANG Cuiying, LI Hui, DONG Li, LV Shuang. Clinical study of acupoint sticking therapy for malignant tumors in patients with chemotherapy-induced nausea and vomiting[J]. Journal of Clinical Medicine in Practice, 2013, (19): 78-79. DOI: 10.7619/jcmp.201319027
    [10]CHEN Guoping, ZHOU Ruifang, LI Shuqin. Nursing intervention for tumor patients with nausea and vomiting caused by chemotherapy[J]. Journal of Clinical Medicine in Practice, 2013, (4): 10-12. DOI: 10.7619/jcmp.201304004

Catalog

    Article views (133) PDF downloads (8) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return